Apripitant 80/125 Cap (Aprecap) is a prescription medicine used to prevent nausea and vomiting caused by chemotherapy. It belongs to the neurokinin-1 (NK1) receptor antagonist class, which works by blocking signals in the brain that trigger vomiting. Widely recommended in supportive cancer care, Aprecap ensures better tolerance of chemotherapy treatment. For further clinical details, you may visit Mayo Clinic, Drugs.com, and FDA.

Key Benefits & Uses

• Prevents acute and delayed nausea/vomiting after chemotherapy.

• Enhances patient comfort and treatment adherence.

• Works in combination with other antiemetic medicines for maximum effect.

• Improves overall quality of life during cancer therapy.
  For more research insights, check PubMed and Healthline.

How to Use

• Usually taken as one 125 mg capsule before chemotherapy on Day 1, followed by 80 mg capsules on subsequent days (as prescribed by your doctor).

• Swallow whole with water, with or without food.

• Always follow the dosage schedule given by your healthcare provider.

Important Safety Information

• Not suitable for people allergic to aprepitant or any capsule ingredient.

• Inform your doctor about all current medications to avoid drug interactions.

• Use with caution in patients with liver disease.

• Pregnant or breastfeeding women should consult their doctor before use.
  Detailed guidelines are available at WHO and WebMD.

Common Side Effects

• Tiredness or fatigue

• Hiccups

• Indigestion or loss of appetite

• Mild constipation or diarrhea

• Headache or dizziness

Seek medical help if severe allergic reactions or unusual symptoms occur.

Why Choose Apripitant (Aprecap)?

• Clinically proven effectiveness in preventing chemotherapy-induced nausea and vomiting.

• Trusted by oncologists worldwide.

• Backed by extensive research and approval from global health authorities.

• Helps patients complete their cancer treatment with fewer interruptions.